|
1
|
Crocetti E, Trama A, Stiller C, Caldarella
A, Soffietti R, Jaal J, Weber DC, Ricardi U, Slowinski J and
Brandes A; RARECARE working group, : Epidemiology of glial and
non-glial brain tumours in Europe. Eur J Cancer. 48:1532–1542.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ricard D, Idbaih A, Ducray F, Lahutte M,
Hoang-Xuan K and Delattre JY: Primary brain tumours in adults.
Lancet. 379:1984–1996. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de-Almeida-Sassi F, Lunardi-Brunetto A,
Schwartsmann G, Roesler R and Abujamra AL: Glioma revisited: From
neurogenesis and cancer stem cells to the epigenetic regulation of
theniche. J Oncol. 2012:5378612012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lima FR, Kahn SA, Soletti RC, Biasoli D,
Alves T, da Fonseca AC, Garcia C, Romão L, Brito J, Holanda-Afonso
R, et al: Glioblastoma: Therapeutic challenges, what lies ahead.
Biochim Biophys Acta. 1826:338–349. 2012.PubMed/NCBI
|
|
5
|
Shahar T, Nossek E, Steinberg DM, Rozovski
U, Blumenthal DT, Bokstein F, Sitt R, Freedman S, Corn BW, Kanner
AA and Ram Z: The impact of enrollment in clinical trials on
survival of patients with glioblastoma. J Clin Neurosci.
19:1530–1534. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shao J, Zheng D, Jiang Z, Xu H, Hu Y, Li X
and Lu X: Curcumin delivery by methoxy polyethylene
glycol-poly(caprolactone) nanoparticles inhibits the growth of C6
glioma cells. Acta Biochim Biophys Sin (Shanghai). 43:267–274.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang YB, Hu Y, Li Z, Wang P, Xue YX, Yao
YL, Yu B and Liu YH: Artemether combined with shRNA interference of
vascular cell adhesion molecule-1 significantly inhibited the
malignant biological behavior of human glioma cells. PLoS One.
8:e608342013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang FY, Hu Y, Que ZY, Wang P, Liu YH,
Wang ZH and Xue YX: Shikonin inhibits the migration and invasion of
human glioblastoma cells by targeting phosphorylated β-catenin and
phosphorylated PI3K/Akt: A potential mechanism for the anti-glioma
efficacy of a traditional chinese herbal medicine. Int J Mol Sci.
16:23823–23848. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tundis R, Bonesi M, Deguin B, Loizzo MR
and Menichini F, Conforti F, Tillequin F and Menichini F: Cytotoxic
activity and inhibitory effect on nitric oxide production of
triterpene saponins from the roots of Physospermum verticillatum
(Waldst & Kit) (Apiaceae). Bioorg Med Chem. 17:4542–4547. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Q, Zheng XL, Yang L, Shi F, Gao LB,
Zhong YJ, Sun H, He F, Lin Y and Wang X: Reactive oxygen
species-mediated apoptosis contributes to chemosensitization effect
of saikosaponins on cisplatin-induced cytotoxicity in cancer cells.
J Exp Clin Cancer Res. 29:1592010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang BF, Lin S, Bai MH, Song LQ, Min WL,
Wang M, Yang P, Ma HB and Wang XJ: Effects of SSd combined with
radiation on inhibiting SMMC-7721 hepatoma cell growth. Med Sci
Monit. 20:1340–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wong VK, Li T, Law BY, Ma ED, Yip NC,
Michelangeli F, Law CK, Zhang MM, Lam KY, Chan PL and Liu L:
Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell
death in apoptosis-defective cells. Cell Death Dis. 4:e7202013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wong VK, Zhang MM, Zhou H, Lam KY, Chan
PL, Law CK, Yue PY and Liu L: Saikosaponin-d enhances the
anticancer potency of TNF-α via overcoming its undesirable response
of activating NF-kappa B signalling in cancer cells. Evid Based
Complement Alternat Med. 2013:7452952013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hsu YL, Kuo PL, Chiang LC and Lin CC:
Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in
induction of apoptosis and cell cycle arrest by saikosaponin d in
human hepatoma cell lines. Cancer Lett. 213:213–221. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Acharya AS, Acharya NK and Dash AP:
Software for estimating LD50 and LD90 by logit analysis. Comput
Methods Programs Biomed. 34:255–256. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nesbitt SA and Horton MA: A nonradioactive
biochemical characterization of membrane proteins using enhanced
chemiluminescence. Anal Biochem. 206:267–272. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin X, Wu S, Wang Q, Shi Y, Liu G, Zhi J
and Wang F: Saikosaponin-D reduces H2O2-induced PC12 cell apoptosis
by removing ROS and blocking MAPK-dependent oxidative damage. Cell
Mol Neurobiol. 36:1365–1375. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang P, Ren J, Tang J, Zhang D, Li B and
Li Y: Estrogen-like activities of saikosaponin-d in vitro: A pilot
study. Eur J Pharmacol. 626:159–165. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: A basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT,
Liu B and Bao JK: Programmed cell death pathways in cancer: A
review of apoptosis, autophagy and programmed necrosis. Cell
Prolif. 45:487–498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kin KL and Cidlowski JA: Cell cycle
regulation and apoptosis. Annu Rev Physiol. 60:601–617. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Townson JL, Naumov GN and Chambers AF: The
role of apoptosis in tumor progression and metastasis. Curr Mol
Med. 3:631–642. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saddoughi SA, Song P and Ogretmen B: Roles
of bioactive sphingolipids in cancer biology and therapeutics.
Subcell Biochem. 49:413–440. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He S, Lu G, Hou H, Zhao Z, Zhu Z, Lu X,
Chen J and Wang Z: Saikosaponin-d suppresses the expression of
cyclooxygenase-2 through the phospho-signal transducer and
activator of transcription 3/hypoxia-inducible factor-1α pathway in
hepatocellular carcinoma cells. Mol Med Rep. 10:2556–2562.
2014.PubMed/NCBI
|
|
27
|
Jang MJ, Kim YS, Bae EY, Oh TS, Choi HJ,
Lee JH, Oh HM and Lee SW: Saikosaponin D isolated from Bupleurum
falcatum inhibits selectin-mediated cell adhesion. Molecules.
19:20340–20349. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu RY and Li JP: Saikosaponin-d inhibits
proliferation of human undifferentiated thyroid carcinoma cells
through induction of apoptosis and cell cycle arrest. Eur Rev Med
Pharmacol Sci. 18:2435–2443. 2014.PubMed/NCBI
|
|
29
|
Davis WJ, Lehmann PZ and Li W: Nuclear
PI3K signaling in cell growth and tumorigenesis. Front Cell Dev
Biol. 3:242015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wymann MP, Zvelebil M and Laffargue M:
Phosphoinositide 3-kinase signalling-which way to target? Trends
Pharmacol Sci. 24:366–376. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
OuYang F, Wang G, Guo W, Zhang Y, Xiang W
and Zhao M: AKT signalling and mitochondrial pathways are involved
in mushroom polysaccharide-induced apoptosis and G1 or S phase
arrest in human hepatoma cells. Food Chem. 138:2130–2139. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Warfel NA and Kraft AS: PIM kinase (and
Akt) biology and signaling in tumors. Pharmacol Ther. 151:41–49.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nakagawa A, Sullivan KD and Xue D:
Caspase-activated phosphoinositide binding by CNT-1 promotes
apoptosis by inhibiting the AKT pathway. Nat Struct Mol Biol.
21:1082–1090. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Widmann C, Gibson S, Jarpe MB and Johnson
GL: Mitogen-activated protein kinase: Conservation of a
three-kinase module from yeast to human. Physiol Rev. 79:143–180.
1999.PubMed/NCBI
|
|
35
|
Koul HK, Pal M and Koul S: Role of p38 MAP
kinase signal transduction in solid tumors. Genes Cancer.
4:342–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gkouveris I, Nikitakis N, Karanikou M,
Rassidakis G and Skavounou A: JNK1/2 expression and modulation of
STAT3 signaling in oral cancer. Oncol Lett. 12:699–706.
2016.PubMed/NCBI
|
|
37
|
Wang Z, Wang W, Xu S, Wang S, Tu Y, Xiong
Y, Mei J and Wang C: The role of MAPK signaling pathway in the
Her-2-positive meningiomas. Oncol Rep. 36:685–695. 2016.PubMed/NCBI
|
|
38
|
Jin Z and El-Deiry WS: Overview of cell
death signaling pathways. Cancer Biol Ther. 4:139–163. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mazumder S, Plesca D and Almasan A:
Caspase-3 activation is a critical determinant of genotoxic
stress-induced apoptosis. Methods Mol Biol. 414:13–21.
2008.PubMed/NCBI
|
